Delivery Order SPE2DB20D2104-SPE2DB25FMBHQ
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,913.99 Firm Fixed Price Delivery Order contract is for the supply of febuxostat 40 mg tablets. The contract is not set aside and is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical through November 2026. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,972.24 for the supply of 40 mg febuxostat tablets. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,955.44 firm fixed-price delivery order is for the supply of febuxostat 80 mg tablets. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA) for the delivery of febuxostat 40 mg tablets. The $1,330.64 Firm Fixed Price delivery order contract has a completion date of January 9, 2025. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation noted. The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,633.92, is a delivery order contract with a firm fixed price for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,358.43 firm fixed-price delivery order is for the supply of 4559470354 - Febuxostat 40 mg Tablets, 30s. The award has an ultimate completion date of December 30, 2022 and was made on December 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
The federal contract award, SPE2DB20D3505|SPE2DB22FT9R2, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.59 delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2022. This award is associated with Amerisourcebergen's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of febuxostat 40 mg tablets. The contract has a ceiling value of $17,032.46 and a period of performance through August 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.62 firm fixed-price delivery order is for 4,555,679,803 units of the medication febuxostat 80 mg tablets, with a completion date of December 13, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award, SPE2DB22D1106|SPE2DB25FECG4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,725.09 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets to support military healthcare programs. The award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...